Testing a New Drug for Hard-to-Control Asthma
Part of Immune system & allergy, Lungs & breathing clinical trials.
This study tests whether a new drug called frevecitinib can help people with severe asthma that isn't well controlled even with strong inhaled steroid medications. The goal is to see if it reduces asthma attacks and improves breathing.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have been diagnosed with asthma for at least 12 months
- You take medium-to-high dose inhaled steroid plus another asthma controller medication, with a stable dose for at least 4 weeks
- You have had at least one asthma attack in the past 12 months despite being on asthma medications
- Your lung function tests show specific results (FEV1 between 40% and 80% of predicted, and reversibility after using a rescue inhaler)
- You do not smoke currently and have never been a heavy smoker (less than 10 pack-years)
- You are willing to use an electronic diary device with at least 80% compliance and complete required lung function tests
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests an add-on medicine called GB-0895 for people with severe asthma that is not well controlled with current treatments. It aims to see if adding this drug can reduce asthma attacks and improve breathing.
This trial tests an add-on treatment called GB-0895 for people with severe asthma that is not well controlled with current medications. It aims to see if adding this drug can reduce asthma attacks and improve lung function.
This study tests an investigational drug to see if it can improve asthma control in people whose asthma is not well managed with current treatments. It may help reduce symptoms and improve lung function.
This study tests a new injected medicine (RC1416) for people with moderate-to-severe asthma that is not well controlled with daily inhalers. It may help reduce asthma attacks and improve breathing.
This study tests a new medicine called PF-07275315 for people with moderate-to-severe asthma that is not well controlled with their current inhalers. It is for adults who have had asthma for at least a year, have had recent flare-ups needing steroids, and are not taking other biologic treatments.
This study is testing whether an investigational drug called GSK5784283 can improve asthma control compared to a placebo. It is for people with uncontrolled asthma who are already on standard daily asthma medications.
Hear when a new Severe Asthma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.